OxRML/AgentSLR huggingface dataset:
Parameter: Pregnancy loss proportion (Other transmission parameters)
Value:   (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 1 / 4 (method: Naive)
Trimester exposed: Whole pregnancy
Women or infants: women
Pregnancy outcome type: miscarriage
Population: Pregnant women, sex: Female, ages  to 
Country: Spain
Setting: Travel based, 
Sample size: 195
Study period: Jan 2016 - Feb 2020
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 38.5 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Unspecified
Numerator/denominator: 104 /  (method: )
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: women
Pregnancy outcome type: CZS
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Hospital based, Urban area
Sample size: 104
Study period: Nov 2015 - Feb 2016
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Suspected
Numerator/denominator: 0 / 616 (method: Naive)
Trimester exposed: Third trimester
Women or infants: women
Pregnancy outcome type: microcephaly
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Setting: Other, Both urban and rural areas
Sample size: 616
Study period: 9 Aug 2015 - 2 Apr 2016
Parameter: Pregnancy loss proportion (Other transmission parameters)
Value:  Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 1 / 6 (method: Naive)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: women
Pregnancy outcome type: miscarriage
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: São Paulo
Setting: Hospital based, 
Sample size: 6
Study period: Jan 2016 - Sep 2016
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Other)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 6 (method: Naive)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: women
Pregnancy outcome type: CZS
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: São Paulo
Setting: Hospital based, 
Sample size: 6
Study period: 1 Jan 2016 - Sep 2016
Parameter: Pregnancy loss proportion (Other transmission parameters)
Value:   (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 11 / 546 (method: Naive)
Statistical approach: Observed sample statistic
Trimester exposed: Whole pregnancy
Women or infants: women
Pregnancy outcome type: miscarriage
Population: Pregnant women, sex: Female, ages  to 
Country: France
Location: Guadeloupe, Martinique, French Guiana
Setting: Other, 
Sample size: 546
Study period: 2 Mar 2016 - 24 Nov 2016
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value:  Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 17 / 320 (method: Naive)
Statistical approach: Observed sample statistic
Trimester exposed: Whole pregnancy
Women or infants: women
Pregnancy outcome type: microcephaly
Population: Children, sex: Both, ages  to 
Country: France
Location: Guadeloupe, Martinique, French Guiana
Setting: Other, 
Sample size: 320
Study period: 2 Mar 2016 - 24 Nov 2016
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 24.7 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 53 / 219 (method: Naive)
Statistical approach: Observed sample statistic
Trimester exposed: Whole pregnancy
Women or infants: newborns referred for potential ZIKV exposure based on abnormal prenatal ultrasonographic findings suggestive of fetal ZIKV infection, maternal nonspecific
viral symptoms, or laboratory assay results positive for ZIKV during pregnancy (most were referred for ZIKV+ mothers)
Pregnancy outcome type: microcephaly
Population: Pregnant women, sex: Both, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Hospital based, 
Sample size: 219
Study period: Sep 2015 - Jun 2017
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 11.33 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 2952 / 26066 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Brazil
Setting: Population based, 
Sample size: 26066
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 1.24 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 248 / 19993 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Colombia
Setting: Population based, 
Sample size: 19993
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 9.9 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 140 / 1414 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Guatemala
Setting: Population based, 
Sample size: 1414
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 8.8 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 85 / 966 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Dominican Republic
Setting: Population based, 
Sample size: 966
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 1.16 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 47 / 4047 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: United States
Location: Puerto Rico
Setting: Population based, 
Sample size: 4047
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0.35 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 20 / 5667 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Mexico
Setting: Population based, 
Sample size: 5667
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 9.05 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 19 / 210 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Costa Rica
Setting: Population based, 
Sample size: 210
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 8.02 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 17 / 212 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Panama
Setting: Population based, 
Sample size: 212
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 3.67 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 17 / 463 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Trinidad and Tobago
Setting: Population based, 
Sample size: 463
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 1.54 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 14 / 912 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Ecuador
Setting: Population based, 
Sample size: 912
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 7.41 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 14 / 189 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Bolivia
Setting: Population based, 
Sample size: 189
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 1.17 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 8 / 681 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Honduras
Setting: Population based, 
Sample size: 681
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0.6 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 5 / 830 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Martinique
Setting: Population based, 
Sample size: 830
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0.61 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 5 / 815 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Guadeloupe
Setting: Population based, 
Sample size: 815
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 1.02 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 4 / 391 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: El Salvador
Setting: Population based, 
Sample size: 391
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0.18 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 2 / 1117 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Nicaragua
Setting: Population based, 
Sample size: 1117
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 6.45 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 2 / 31 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Paraguay
Setting: Population based, 
Sample size: 31
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0.05 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 1 / 2211 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: French Guiana
Setting: Population based, 
Sample size: 2211
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 4.55 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 1 / 22 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Haiti
Setting: Population based, 
Sample size: 22
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 2.08 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 1 / 48 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: St. Martin (French part)
Setting: Population based, 
Sample size: 48
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 3.13 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 1 / 32 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Barbados
Setting: Population based, 
Sample size: 32
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 3463 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Venezuela
Setting: Population based, 
Sample size: 3463
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 712 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Jamaica
Setting: Population based, 
Sample size: 712
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 279 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Peru
Setting: Population based, 
Sample size: 279
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 30 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Curaçao
Setting: Population based, 
Sample size: 30
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 1 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Belize
Setting: Population based, 
Sample size: 1
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 13 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Dominica
Setting: Population based, 
Sample size: 13
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 3 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: St. Vincent and the Grenadines
Setting: Population based, 
Sample size: 3
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 16 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Antigua and Barbuda
Setting: Population based, 
Sample size: 16
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 286 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Virgin Islands (U.S.)
Setting: Population based, 
Sample size: 286
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 10 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Sint Maarten (Dutch part)
Setting: Population based, 
Sample size: 10
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed or suspected
Numerator/denominator: 0 / 84 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: Unspecified
Location: Saint Lucia
Setting: Population based, 
Sample size: 84
Study period: May 2015 - Jan 2018
Parameter: Zika congenital syndrome (microcephaly) proportion (Other transmission parameters)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Confirmed
Numerator/denominator: 0 / 11 (method: Unspecified)
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Women or infants: surveillance reports with ns of infected women and nx of CZS cases
Pregnancy outcome type: CZS
Population: General population, sex: Unspecified, ages  to 
Country: France
Location: Saint Barthelemy
Setting: Population based, 
Sample size: 11
Study period: May 2015 - Jan 2018